首页> 外文期刊>Endocrine journal >Clinical Implication of Serial Leptin Measurement in Subjects with Type 2 Diabetes Mellitus
【24h】

Clinical Implication of Serial Leptin Measurement in Subjects with Type 2 Diabetes Mellitus

机译:2型糖尿病患者连续瘦素测定的临床意义

获取原文
       

摘要

References(26) Cited-By(4) Plasma leptin concentration is closely associated with body fat in humans, with energy restriction inducing a greater decrease in plasma leptin than in body fat. Since adequate energy restriction is mandatory in diet therapy of diabetes mellitus especially in obese subjects, the present study was undertaken to evaluate the clinical implication of serial leptin measurement in the management of diabetic patients. Fifty-four consecutive subjects with type 2 diabetes, who were subjected to adjusted energy restriction during hospitalization, were enrolled in the study. During their hospitalization period (24±4 days), plasma leptin concentrations decreased from 6.9±0.7 to 5.7±0.6pg/l (P0.0001) in the overall subjects, and the %change in plasma leptin (-13.9%) was greater than the %changes in body mass index (BMI) and percent body fat (-1.7% and -4.7%, respectively). The %change in plasma leptin was positively correlated with the %changes in BMI and plasma C-peptide (r=0.526, P0.0001 and r=0.446, P0.002, respectively) and negatively with a %change in plasma ketone bodies (r=-0.516, P0.005). Multiple regression analysis revealed that the %changes in BMI and plasma C-peptide were independent determinants of the %change in plasma Leptin. In addition, 38 subjects were followed up after discharge. Three months after discharge, plasma leptin concentrations significantly increased by 25.6%, which was again much greater than the %change in BMI (+0.9%). In 28 subjects who showed increase in plasma leptin levels after discharge, BMI was also increased. In contrast, the remaining 10 subjects without the increase in plasma leptin kept their BMI unchanged. Throughout the observation period, the changes in plasma leptin were prominent in the subjects with BMI greater than 25kg/m2. In conclusion, plasma leptin concentrations showed greater changes than the alterations in anthropometric indexes during the observation period. Serial leptin measurement may be useful to estimate adherence to energy restriction especially in obese subjects with type 2 diabetes.
机译:参考文献(26)被引用的By(4)血浆瘦素浓度与人体内的脂肪密切相关,能量限制导致血浆瘦素的降低幅度大于体内脂肪。由于在糖尿病的饮食疗法中,尤其是在肥胖受试者中,必须有足够的能量限制,因此本研究旨在评估连续瘦素测量在糖尿病患者管理中的临床意义。这项研究纳入了54名连续2型糖尿病患者,他们在住院期间接受了适当的能量限制。在其住院期间(24±4天),血浆瘦素浓度从总体受试者的6.9±0.7降至5.7±0.6pg / l(P <0.0001),血浆瘦素的变化百分比(-13.9%)更大比体重指数(BMI)和身体脂肪百分比的变化百分比(分别为-1.7%和-4.7%)。血浆瘦素的变化百分比与BMI和血浆C肽的变化百分比呈正相关(分别为r = 0.526,P <0.0001和r = 0.446,P <0.002),与血浆酮体的%变化呈负相关( r = -0.516,P <0.005)。多元回归分析显示,BMI和血浆C肽的变化百分比是血浆瘦素变化百分比的独立决定因素。此外,出院后对38名受试者进行了随访。出院后三个月,血浆瘦素浓度显着增加了25.6%,再次高于BMI的变化百分比(+ 0.9%)。在出院后血浆瘦素水平升高的28位受试者中,BMI也升高。相比之下,其余10名受试者的血浆瘦素没有增加,但其BMI保持不变。在整个观察期内,BMI大于25kg / m2的受试者血浆中瘦素的变化最为明显。总之,在观察期内,血浆瘦素浓度的变化大于人体测量指标的变化。连续进行瘦素测量可能有助于评估对能量限制的依从性,尤其是在患有2型糖尿病的肥胖患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号